T42	Exp 125 127	We
T43	Exp 147 151	that
T44	Exp 325 327	We
T45	Exp 344 348	that
T46	Exp 571 596	the transcriptional level
T47	Exp 630 634	that
T48	Exp 979 983	both
T49	Exp 913 923	the levels
T50	Exp 1045 1084	The CHO-DR/B7/LFA-3 triple transfectant
T51	Exp 1166 1190	the double transfectants
T52	Exp 1192 1201	The level
T53	Exp 1291 1295	that
T54	Exp 1296 1318	the NF-kappa B complex
T55	Exp 1447 1472	The AP-1 binding proteins
T56	Exp 1549 1560	Our results
T57	Exp 1620 1632	the activity
T58	Exp 1686 1710	the differential effects
T59	SPAN 852 947	LFA-3 induced moderate levels of AP-1, but did not influence the levels of NF-kappa B, while B7
R8	Coref Anaphora:T48 Antecedent:T59
T1	Protein 23 26	CD4
T2	Protein 41 46	LFA-3
T3	Protein 51 53	B7
T4	Protein 173 176	CD4
T5	Protein 273 275	B7
T6	Protein 279 284	LFA-3
T7	Protein 349 351	B7
T8	Protein 361 366	LFA-3
T9	Protein 390 394	IL-2
T10	Protein 432 435	CD4
T11	Protein 466 470	IL-2
T12	Protein 510 512	B7
T13	Protein 513 518	LFA-3
T14	Protein 555 557	B7
T15	Protein 562 567	LFA-3
T16	Protein 650 653	CD4
T17	Protein 852 857	LFA-3
T18	Protein 945 947	B7
T19	Protein 1056 1058	B7
T20	Protein 1059 1064	LFA-3
T21	Protein 1335 1338	CD4
T22	Protein 1375 1378	p50
T23	Protein 1403 1406	p65
T24	Protein 1431 1436	c-Rel
T25	Protein 1483 1488	c-Jun
T26	Protein 1490 1495	Jun-D
T27	Protein 1501 1506	Fra-1
T28	Protein 1532 1537	Jun-B
T29	Protein 1542 1547	c-Fos
T30	Protein 1590 1592	B7
T31	Protein 1597 1602	LFA-3
T32	Protein 1714 1716	B7
T33	Protein 1721 1726	LFA-3
T34	Protein 1744 1748	IL-2
